A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and preliminary efficacy of single intraarticular injections of three dose levels of SYN321 and placebo in patients with symptomatic knee osteoarthritis
RecruitingCTIS2024-517920-21-00
Synartro ABknee osteoarthritis
Start: 2025-08-19Target: 36Updated: 2025-11-17